Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BPESC1 is a long non-coding RNA (lncRNA) gene located in a chromosomal region that has been proposed as a candidate for involvement in blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES), mainly due to structural variants such as deletions affecting the FOXL2 region or surrounding regulatory elements. BPESC1 itself does not encode a known protein, nor is it a recognized receptor, enzyme, or therapeutic target. While it has been referenced in studies of regulatory elements near FOXL2, no direct molecular function or therapeutic relevance has been established. The gene is annotated in multiple databases as a non-coding RNA with no verified molecular activity or disease causality. There are no known drugs or biomarkers associated with this locus. Most functional studies in BPES implicate FOXL2 protein-coding gene, not BPESC1. BPESC1 is not considered a canonical therapeutic target, and its attribution as a disease-associated gene represents likely confusion with more definitively validated protein-coding genes in the same genomic region.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blepharophimosis, epicanthus inversus and ptosis candidate 1 (non-protein coding) (BPESC1).